173 related articles for article (PubMed ID: 14657442)
41. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
Simon SD; Srougi M
Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
[No Abstract] [Full Text] [Related]
42. M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.
Scher H; Herr H; Sternberg C; Fair W; Bosl G; Morse M; Sogani P; Watson R; Darshaw D; Reuter V
Prog Clin Biol Res; 1990; 353():179-86. PubMed ID: 2217417
[No Abstract] [Full Text] [Related]
43. Neoadjuvant chemotherapy in deeply invasive bladder cancer: the Italian experience. The Lombard Urologists.
Semin Urol; 1990 Aug; 8(3):205-9. PubMed ID: 2204982
[No Abstract] [Full Text] [Related]
44. [Neoadjuvant chemotherapy of infiltrating carcinoma of the bladder: our experience].
Graziotti P; Personeni A; Benzone S; Giannone C; Giardina G; Guizzetti C; Ranieri A; Romano C; Taino R; Lembo A
Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):223-9. PubMed ID: 2142805
[TBL] [Abstract][Full Text] [Related]
45. Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080).
Crawford ED; Natale RB; Burton H
Prog Clin Biol Res; 1990; 353():111-3. PubMed ID: 2217407
[No Abstract] [Full Text] [Related]
46. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Wei CH; Hsieh RK; Chiou TJ; Chen KK; Chang LS; Chen PM
J Urol; 1996 Jan; 155(1):118-21. PubMed ID: 7490806
[TBL] [Abstract][Full Text] [Related]
47. [Place of chemotherapy in the treatment of invasive bladder tumors].
Pariente JL; Theodore C; Davin JL; Rischmann P; Chopin D
Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944
[TBL] [Abstract][Full Text] [Related]
48. [The SWOG-8710/INT-0080 study: innovations and controversies concerning neoadjuvant treatment of locally advanced bladder cancer].
Nelli F
Suppl Tumori; 2004; 3(4):S57-8. PubMed ID: 15206214
[No Abstract] [Full Text] [Related]
49. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Bex A; Nieuwenhuijzen JA; Kerst M; Pos F; van Boven H; Meinhardt W; Horenblas S
Urology; 2005 Feb; 65(2):295-9. PubMed ID: 15708041
[TBL] [Abstract][Full Text] [Related]
50. Systemic chemotherapy for muscle invasive bladder cancer.
Ondrus D; Hornák M; Bárdos A; Ondrus B
Neoplasma; 1994; 41(5):263-8. PubMed ID: 7854496
[TBL] [Abstract][Full Text] [Related]
51. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
Sternberg CN; Yagoda A; Scher HI
Prog Clin Biol Res; 1988; 277():45-51. PubMed ID: 3054909
[No Abstract] [Full Text] [Related]
52. [Bladder cancer chemotherapy practice study].
Clippe C; Clippe S; Yzebe D; Flechon A; Droz JP
Prog Urol; 2002 Sep; 12(4):609-14. PubMed ID: 12463119
[TBL] [Abstract][Full Text] [Related]
53. Chemotherapy for bladder cancer.
Sonpavde G; Rawat A; Naveed F
N Engl J Med; 2003 Dec; 349(23):2272-3; author reply 2272-3. PubMed ID: 14663870
[No Abstract] [Full Text] [Related]
54. [New chemotherapy regimens for advanced bladder cancer].
Fagbemi SO; Stadler WM
Actas Urol Esp; 1998 Jun; 22(6):548-9. PubMed ID: 9734137
[No Abstract] [Full Text] [Related]
55. Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.
Droller MJ
J Urol; 2002 May; 167(5):2297-8. PubMed ID: 11956495
[No Abstract] [Full Text] [Related]
56. [Penile metastasis from bladder cancer. A case report].
Gentile V; Mariotti G; Fattore F; Cardi A; Di Silverio F
Minerva Urol Nefrol; 2002 Jun; 54(2):129-30. PubMed ID: 12070461
[TBL] [Abstract][Full Text] [Related]
57. Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder.
Benson MC
Ann Oncol; 1999 Nov; 10(11):1269-70. PubMed ID: 10631452
[No Abstract] [Full Text] [Related]
58. [Adjuvant chemotherapy in infiltrating bladder carcinoma. Long-term results].
Marino G; Cocimano V; Cevoli R; Marten Perolino R
Minerva Urol Nefrol; 1993 Sep; 45(3):113-5. PubMed ID: 8278877
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of the influence of systemic neoadjuvant chemotherapy on the survival of patients treated for invasive bladder cancer.
Kolaczyk W; Dembowski J; Lorenz J; Dudek K
BJU Int; 2002 Apr; 89(6):616-9. PubMed ID: 11942977
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer: bridging the gap between evidence and practice.
Sfakianos JP; Galsky MD
Urol Clin North Am; 2015 May; 42(2):181-7, viii. PubMed ID: 25882560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
